• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to "Predictors of survival in thrombotic thrombocytopenic purpura" Haematologica 2013;98(5):e58.

作者信息

Coppo Paul

出版信息

Haematologica. 2013 Jul;98(7):e80. doi: 10.3324/haematol.2013.091504.

DOI:10.3324/haematol.2013.091504
PMID:23813652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3696600/
Abstract
摘要

相似文献

1
Response to "Predictors of survival in thrombotic thrombocytopenic purpura" Haematologica 2013;98(5):e58.对《血栓性血小板减少性紫癜的生存预测因素》的回应 血液学杂志2013年；98(5):e58
Haematologica. 2013 Jul;98(7):e80. doi: 10.3324/haematol.2013.091504.
2
Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.血栓性血小板减少性紫癜和其他血栓性微血管病性溶血性贫血：诊断和分类。
Autoimmun Rev. 2014 Apr-May;13(4-5):584-6. doi: 10.1016/j.autrev.2014.01.004. Epub 2014 Jan 11.
3
Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?恶性高血压与溶血尿毒综合征（HUS）/血栓性血小板减少性紫癜（TTP）中的血栓性微血管病：我们能将两者区分开吗？
Hypertens Res. 2005 Jan;28(1):89-95. doi: 10.1291/hypres.28.89.
4
Predictors of survival in thrombotic thrombocytopenic purpura.
Haematologica. 2013 May;98(5):e58. doi: 10.3324/haematol.2012.079400.
5
[Thrombotic thrombocytopenic purpura].[血栓性血小板减少性紫癜]
Rinsho Ketsueki. 2021;62(5):430-434. doi: 10.11406/rinketsu.62.430.
6
An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜发病机制和诊断的研究进展。
Expert Rev Hematol. 2019 Jun;12(6):383-395. doi: 10.1080/17474086.2019.1611423. Epub 2019 May 20.
7
Recent advances in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的最新进展
Hematology Am Soc Hematol Educ Program. 2004:407-23. doi: 10.1182/asheducation-2004.1.407.
8
The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.血栓性血小板减少性紫癜与非典型溶血尿毒综合征的复杂鉴别诊断：实验室武器及其对治疗选择和监测的影响。
Thromb Res. 2015 Nov;136(5):851-4. doi: 10.1016/j.thromres.2015.09.007. Epub 2015 Sep 12.
9
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.异基因造血干细胞移植后血栓性血小板减少性紫癜-溶血性尿毒症综合征：诊断困境
Transfusion. 2004 Feb;44(2):294-304. doi: 10.1111/j.1537-2995.2004.00700.x.
10
The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.血栓性血小板减少性紫癜和溶血性尿毒症综合征：1989 - 2007年俄克拉荷马州血栓性血小板减少性紫癜-溶血性尿毒症综合征登记处的评估、管理及长期预后经验
Kidney Int Suppl. 2009 Feb(112):S52-4. doi: 10.1038/ki.2008.622.

本文引用的文献

1
Predictors of survival in thrombotic thrombocytopenic purpura.
Haematologica. 2013 May;98(5):e58. doi: 10.3324/haematol.2012.079400.
2
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.依库珠单抗在非典型溶血尿毒综合征和 C3 肾小球病中的应用。
Nat Rev Nephrol. 2012 Nov;8(11):643-57. doi: 10.1038/nrneph.2012.214. Epub 2012 Oct 2.
3
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.获得性严重 ADAMTS13 缺乏相关性特发性血栓性血小板减少性紫癜死亡预测模型的建立和验证：法国 TMA 参考中心经验。
Haematologica. 2012 Aug;97(8):1181-6. doi: 10.3324/haematol.2011.049676. Epub 2012 May 11.
4
Autoimmune thrombotic microangiopathy: advances in pathogenesis, diagnosis, and management.自身免疫性血栓性微血管病：发病机制、诊断和治疗的进展。
Semin Thromb Hemost. 2012 Jul;38(5):469-82. doi: 10.1055/s-0032-1306431. Epub 2012 Apr 3.
5
The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies.利用ADAMTS13活性、血小板计数和血清肌酐来鉴别获得性血栓性血小板减少性紫癜与其他血栓性微血管病。
Br J Haematol. 2012 May;157(4):501-3. doi: 10.1111/j.1365-2141.2012.09032.x. Epub 2012 Feb 1.
6
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.一线利妥昔单抗治疗对血浆置换反应不佳的严重获得性血栓性血小板减少性紫癜的疗效和安全性。法国血栓性微血管病参考中心的经验。
Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.
7
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.一项评估利妥昔单抗联合血浆置换治疗急性获得性血栓性血小板减少性紫癜的安全性和有效性的 2 期研究。
Blood. 2011 Aug 18;118(7):1746-53. doi: 10.1182/blood-2011-03-341131. Epub 2011 Jun 2.
8
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.特发性血栓性微血管病中严重获得性 ADAMTS13 缺乏症的预测特征：法国 TMA 参考中心的经验。
PLoS One. 2010 Apr 23;5(4):e10208. doi: 10.1371/journal.pone.0010208.
9
The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange.患者特征在预测严重 ADAMTS13 缺乏症和对血浆置换反应中的作用。
Transfusion. 2010 Aug;50(8):1654-64. doi: 10.1111/j.1537-2995.2010.02653.x. Epub 2010 Apr 20.
10
Thrombotic microangiopathies: towards a pathophysiology-based classification.血栓性微血管病：迈向基于病理生理学的分类
Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):36-50. doi: 10.2174/187152909787581318.